Document 0695
 DOCN  M95A0695
 TI    HIV conference spotlights women's concerns. 
 DT    9510
 SO    AIDS Alert. 1995 Apr;10(4):54-7. Unique Identifier : AIDSLINE
       AIDS/95700226
 AB    The HIV Infection in Women: Setting a New Agenda conference in
       Washington, DC, brought together researchers, providers, and HIV-
       positive women to discuss AIDS among women. The U.S. Public Health
       Service announced draft guidelines on counseling and testing of all
       pregnant women for HIV. These guideline were made in response to the
       1994 clinical finding of ACTG 076 that the use of zidovudine (AZT,
       Retrovir) significantly decreases transmission of HIV from mothers to
       newborns. Other conference attendees expressed mistrust of AZT as a safe
       and effective treatment and criticized the Food and Drug Administration
       (FDA) for slow approval of AIDS drugs and for failing to include women
       in clinical trials. A representative of the Clinton administration told
       attendees that approximately $20 million has been allocated in the 1995
       National Institutes of Health budget to study female control barriers,
       and an additional $724 million has been proposed for the Ryan White Care
       Act. In addition, participants heard information on six ongoing women's
       cohort studies. AIDS is now the fourth leading cause of death among
       American women ages 25 to 44.
 DE    Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY  Clinical Trials  Female
       Guidelines  HIV Infections/EPIDEMIOLOGY  Human  Pregnancy  Pregnancy
       Complications, Infectious  Prevalence  *Women's Health  NEWSLETTER
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).